| CTRI Number |
CTRI/2024/06/068299 [Registered on: 04/06/2024] Trial Registered Prospectively |
| Last Modified On: |
30/03/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Effect of low-dose intrathecal (within the spinal space) morphine as a part of multimodal analgesia (which combines various groups of medications for pain relief) in patients aged 18 to 65 years undergoing cardiac surgery by cutting of breast bone. |
|
Scientific Title of Study
|
Effect of low dose intrathecal morphine as a part of multimodal analgesia in patients undergoing cardiac surgeries through sternotomy – open-label randomized control trial. |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Anil Gupta |
| Designation |
DM Cardiac anesthesia resident |
| Affiliation |
All India Institute of Medical Sciences |
| Address |
Department of Anesthesiology
AIIMS Raipur
Great Eastern Road
Tatibandh Raipur CHHATTISGARH 492099 India |
| Phone |
9406090235 |
| Fax |
|
| Email |
aneelgoopta@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Prof. (Dr) Subrata Kumar Singha |
| Designation |
Professor |
| Affiliation |
All India Institute of Medical Sciences |
| Address |
Department of Anesthesiology
AIIMS Raipur
Great Eastern Road
Tatibandh Raipur CHHATTISGARH 492099 India |
| Phone |
9406090235 |
| Fax |
|
| Email |
subratsingh@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Anil Gupta |
| Designation |
DM Cardiac anesthesia resident |
| Affiliation |
All India Institute of Medical Sciences |
| Address |
Department of Anesthesiology
AIIMS Raipur
Great Eastern Road
Tatibandh Raipur CHHATTISGARH 492099 India |
| Phone |
9406090235 |
| Fax |
|
| Email |
aneelgoopta@gmail.com |
|
|
Source of Monetary or Material Support
|
| All India Institute of Medical Sciences, Raipur, Chhattisgarh, India, Pin code- 492099 |
|
|
Primary Sponsor
|
| Name |
All India Institute of Medical Sciences |
| Address |
AIIMS Raipur,
Great Eastern Road, Tatibandh, Raipur, Chhattisgarh, India, Pin Code- 492099
|
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Anil Gupta |
All India Institute of Medical Sciences Raipur |
Department of Anesthesiology, 4th floor, CTVS OT and ICU Raipur CHHATTISGARH |
9406090235
aneelgoopta@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institute Ethics Committee, All India Institute of Medical Sciences, Raipur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: I39||Endocarditis and heart valve disorders in diseases classified elsewhere, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
INTRATHECAL MORPHINE |
Single shot intrathecal 0.1 mg preservative free morphine will be given via 25 gauge Quincke needle either in the L2-L3 or L3-L4 intrathecal space by a midline approach just before induction of anesthesia. They also receive standard treatment i.e., after skin closure USG guided bilateral pectoral intercostal facial plane block (PIFB) will be given using injection 0.25% bupivacaine 20ml and 5 ml of same drug will be infiltrated at drain site. Before extubation, all the patients will receive intravenous paracetamol 1gm followed by 8 hourly during 1st 24 hours of ICU stay. |
| Comparator Agent |
Routine post-operative analgesia |
Only standard treatment i.e., after skin closure USG guided bilateral pectoral intercostal facial plane block (PIFB) will be given using injection 0.25% bupivacaine 20ml and 5 ml of same drug will be infiltrated at drain site. Before extubation, all the patients will receive intravenous paracetamol 1gm followed by 8 hourly during 1st 24 hours of ICU stay. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
Patients aged 18 to 65 years undergoing midline sternotomy for cardiac surgeries, New York Heart Association grade II-III patients |
|
| ExclusionCriteria |
| Details |
Patient refusal to consent, contraindications to intrathecal analgesia such as infection at the injection site, coagulopathy,
and allergy to morphine, pre-existing chronic pain: taking routine analgesics, patients with a history of chronic opiate abuse, patients with psychiatric disorders, patients with previous surgery in thoracic vertebral region, preexisting neurological condition (spinal cord injury, multiple sclerosis, etc.), patients with BMI more than or equal to 35, patients with severe respiratory disease, those expected to be on elective mechanical ventilation for more than 6 hours postoperatively, patients with renal dysfunction (Serum creatinine more than 1.5 mg/dl). |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
On-site computer system |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To assess postoperative pain by visual analogue scale (VAS) score |
upto 24 hour post-operative period |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Total dose of opioids received in the postoperative period (at first 24 hour) |
upto 24 hour post-operative period |
| Time taken for the first dose of rescue analgesia |
in first 24 hour post-operative period |
| To evaluate the incidence of any side effects such as respiratory depression, nausea and vomiting, pruritus, incidence of reintubation and sedation |
upto 24 hour post-operative period |
|
|
Target Sample Size
|
Total Sample Size="104" Sample Size from India="104"
Final Enrollment numbers achieved (Total)= "104"
Final Enrollment numbers achieved (India)="104" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
14/06/2024 |
| Date of Study Completion (India) |
30/11/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
Not yet published |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
|
Title
|
Effect
of low dose intrathecal morphine as a part of multimodal analgesia in
patients undergoing cardiac surgeries through sternotomy - prospective
randomized control trial
|
|
Study center
|
All
India Institute of Medical Sciences, Raipur, India
|
|
Phase
|
Randomized
Control Trial - Phase 3
|
|
Methodology
|
Single-center, open-label randomized controlled trial
|
|
Study duration
|
1.5
years
|
|
Objectives
|
Primary:
To
assess the quality of Analgesia based on VAS pain score in the postoperative
period for 24 hours.
Secondary:
To
assess the total opioid consumption with rescue analgesia and other
associated complications.
|
|
Number of subjects
|
104
|
|
Main inclusion and exclusion criteria
|
Inclusion criteria:
·
Patients of age 18 to 65 years undergoing midline sternotomy for cardiac
surgeries.
·
New York Heart Association grade II-III patients.
Exclusion criteria:
· Patient
refusal. · Contraindication
to intrathecal analgesia: infection at injection site, coagulopathy, allergy
to morphine. ·
Pre-existing chronic pain: taking routine analgesics. ·
Patients with a history of chronic opiate abuse. · Patients with
psychiatric disorders. · Patients with previous surgery in the thoracic
vertebral region. ·
Preexisting neurological condition (spinal cord injury, multiple sclerosis, etc.). ·
Patients with BMI more than or equal to 35. · Patients with
severe respiratory disease. · Those expected to be on elective mechanical
ventilation for >6 hours postoperatively. · Patients with
renal dysfunction (Serum creatinine > 1.5 mg/dl).
|
|
Intervention
|
|
P
|
Population
|
Patients
aged 18 to 65 years undergoing midline sternotomy for cardiac surgeries
|
|
I
|
Intervention
|
Intrathecal morphine
|
|
C
|
Control
|
Standard treatment
|
|
O
|
Outcomes
|
Postoperative
pain by visual analogue scale (VAS) score
|
|
|
Outcomes
|
Primary outcome: To assess postoperative pain by visual analogue
scale (VAS) score.
Secondary outcome: 1. Total dose of opioids received in the postoperative period (at first
24 hours). 2. Time taken for the first dose of rescue analgesia. 3. To
evaluate the incidence of any side effects: Respiratory depression, nausea, and vomiting, pruritus, the incidence of reintubation, sedation
|
|